Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia

Thorax

Volumn 70, Issue 1, 2015, Pages 41-47

  Hellyer, Thomas P ^a   Conway Morris, Andrew ^b,c   McAuley, Daniel F ^d,e   Walsh, Timothy S ^b   Anderson, Niall H ^f   Singh, Suveer ^g   Dark, Paul ^h   Roy, Alistair I ⁱ   Baudouin, Simon V ^a,j   Wright, Stephen E ^k   Perkins, Gavin D ^l   Kefala, Kallirroi ^m   Jeffels, Melinda ^a   McMullan, Ronan ^e   O'Kane, Cecilia M ^d   Spencer, Craig ⁿ   Laha, Shondipon ⁿ   Robin, Nicole ^o   Gossain, Savita ^p   Gould, Kate ^k   Ruchaud Sparagano, Marie Hélène ^a   Scott, Jonathan ^a   Browne, Emma M ^a   MacFarlane, James G ^a   Wiscombe, Sarah ^a   Widdrington, John D ^a   Dimmick, Ian ^q   Laurenson, Ian F ^m   Nauwelaers, Frans ^r   Simpson, A John ^a   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

^k FREEMAN HOSPITAL   (United Kingdom)

^l UNIVERSITY OF WARWICK   (United Kingdom)

^m ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

ⁿ LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^o Department of Medical Microbiology Royal Hospitals ^*  (United Kingdom)

^p UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^q NEWCASTLE UNIVERSITY   (United Kingdom)

^r Public Health Laboratory Heart of England NHS Foundation Trust ^*  (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; NEUTROPHIL COLLAGENASE; CYTOKINE;

ADULT; ARTICLE; BACTERIUM CULTURE; BRONCHOSCOPY; COLONY FORMING UNIT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VENTILATOR ASSOCIATED PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; CLINICAL TRIAL; FOLLOW UP; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDY; REPRODUCIBILITY;

BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84919776646     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205766     Document Type: Article

References (28)

1. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
3. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994;106:221-35.
4. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am J Respir Crit Care Med 1988;138:110-16.
5. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262-8.
6. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 2010;65:201-7.
7. Wilkinson TS, Morris AC, Kefala K, et al. Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lung. Chest 2012;142:1425-32.
8. Rouby JJ, Martin De Lassale E, Poete P, et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992;146:1059-66.
9. Health Protection Agency. UK standards for Microbiology investigations. Investigation of Bronchoalveolar Lavage, Sputum and Associated Specimens. Issued by the Standards Unit, Microbiology Services Division, HPA. Issue date 02.08.12.
10. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European Consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994;20:225-32.
11. Team RC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013.
12. Lopez-Ranton M, Rodriguez-Alvarez M. Package "OptimalCutpoints. " 2013. http://cran.rproject.org/web/packages/OptimalCutpoints/OptimalCutpoints.pdf
13. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011;11:181-9.
14. Duflo F, Debon R, Monneret G, et al. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002;96:74-9.
15. Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008;34:1434-40.
16. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004;350:451-8.
17. el-Ebiary M, Torres A, González J, et al. Use of elastin fibre detection in the diagnosis of ventilator associated pneumonia. Thorax 1995;50:14-17.
18. Seligman R, Papassotiriou J, Morgenthaler NG, et al. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008;12:R11.
19. Mathy-Hartert M, Damas P, Nys M, et al. Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia. Eur Respir J 2000;16:296-301.
20. Heyland D, Jiang X, Day AG, et al. Serum β-d-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations. J Crit Care 2011;26:536.e1-9.
21. Boeck L, Graf R, Eggimann P, et al. Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia. Chest 2011;140:925-32.
22. Seligman R, Papassotiriou J, Morgenthaler NG, et al. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med 2008;34:2084-91.
23. Lin Q, Fu F, Shen L, et al. Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity. Heart Lung 2013;42:139-45.
24. Vanspauwen MJ, Linssen CFM, Bruggeman CA, et al. Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?. Crit Care 2011;15:R14.
25. Cobb JP, Moore EE, Hayden DL, et al. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg 2009;250:531-9.
26. Parmentier-Decrucq E, Nseir S, Makris D, et al. Accuracy of leptin serum level in diagnosing ventilator-associated pneumonia: a case-control study. Minerva Anestesiol 2014;80:39-47.
27. Textoris J, Loriod B, Benayoun L, et al. An evaluation of the role of gene expression in the prediction and diagnosis of ventilator-associated pneumonia. Anesthesiology 2011;115:344-52.
28. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995;152:231-40.